TRIFLUOPERAZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trifluoperazine Hydrochloride, and what generic alternatives are available?
Trifluoperazine Hydrochloride is a drug marketed by Fosun Pharma, Wockhardt, Athem, Duramed Pharms Barr, Ivax Pharms, Mylan, Sandoz, and Watson Labs. and is included in twenty NDAs.
The generic ingredient in TRIFLUOPERAZINE HYDROCHLORIDE is trifluoperazine hydrochloride. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the trifluoperazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trifluoperazine Hydrochloride
A generic version of TRIFLUOPERAZINE HYDROCHLORIDE was approved as trifluoperazine hydrochloride by SANDOZ on December 31st, 1969.
Summary for TRIFLUOPERAZINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 20 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 151 |
| Clinical Trials: | 7 |
| Patent Applications: | 172 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TRIFLUOPERAZINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TRIFLUOPERAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Adrianna Vlachos | Phase 1/Phase 2 |
| Lindner Center of HOPE | Phase 2 |
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Pharmacology for TRIFLUOPERAZINE HYDROCHLORIDE
| Drug Class | Phenothiazine |
Medical Subject Heading (MeSH) Categories for TRIFLUOPERAZINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TRIFLUOPERAZINE HYDROCHLORIDE
US Patents and Regulatory Information for TRIFLUOPERAZINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fosun Pharma | TRIFLUOPERAZINE HYDROCHLORIDE | trifluoperazine hydrochloride | CONCENTRATE;ORAL | 085787-001 | Apr 15, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan | TRIFLUOPERAZINE HYDROCHLORIDE | trifluoperazine hydrochloride | TABLET;ORAL | 040209-004 | Jul 7, 1997 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Watson Labs | TRIFLUOPERAZINE HYDROCHLORIDE | trifluoperazine hydrochloride | TABLET;ORAL | 085976-001 | Jun 23, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
